Robert Goldberg-Alberts

Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial

Francesco Paolo Schena, M.D. Pascoe, Josefina Alberú et al. · Transplantation · 2009 · 574 citations

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial

Joshua N. Goldstein, Majed A. Refaai, Truman J. Milling et al. · The Lancet · 2015 · 444 citations

Thrombosis, Cardiovascular Disease, Randomised Trial +6

Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial

Josefina Alberú, M.D. Pascoe, Josep M. Campistol et al. · Transplantation · 2011 · 221 citations

Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial

Manal F. Abdelmalek, Abhinav Humar, Felix Stickel et al. · American Journal of Transplantation · 2012 · 122 citations · Full text

Transplant Rejection, Adverse Events, Transplantation +13

Ecologic Correlates of Cancer Mortality Patterns in an Industrialized Urban Population<xref ref-type="fn" rid="FN2">2</xref>

Hari H. Dayal, C Y Chiu, Robert G. Sharrar et al. · JNCI Journal of the National Cancer Institute · 1984 · 20 citations